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Summary
We have developed a cysteine anchoring method for the synthesis of DILP8 and its analogues. The 
first is to synthesis of DILP8A SS13-18, C14-MeOBzl, C24-Acm and activate it as DILP8A S13-18, 
C14-SSPyr C24-Acm. A next step is to synthesize the DILP8BC16-Acm. The desired peptide, DILP8 
with Cys(Acm) at A-24 and B-16, was then dissolved in 75% HOAc by addition of Iodine in MeOH 
and 4M HCl in dioxane. The reaction mixture was monitored by HPLC and the excess iodine was 
reduced with ascorbic acid. Purification of the peptide was achieved by HPLC. Pure synthetic 
DILP8 showed a single peak on analytical HPLC with corrected molecular ion. By using the above 
methods, enough peptide and highly homogenous pure DILP8 were generated. 
Introduction
Dilp8 shares some sequence homology with the human INSL4 (Figure 1). Since 
Dilp8 has been found to coordinate Drosophila tissue growth with developmen-
tal timing(1), a similar mechanisms has been speculated in disease states in humans 
where alteration in growth or tissue inflammation can delay puberty. However, there 
is no report about the chemical synthesis of this DILP8 yet. 
Methods, Results and Discussion
A solid-phase syntheses of DILP8 has been performed by using the modified 
method as described before(2).
The first in the method is to make DILP8, A chain, S-S 13-18, Cys(S-S-Pyr) 14 and Cys 
(Acm) 24 DHSSRSYNNIPYCC(SSPyr)LNQCEEEFFC(Acm) and the B chain, SFCSLER-
MKKFAMEAC(Acm)EHLFQADEGARRD were dissolved in 50% acetic acid. The reac-
tion was carried out at 50ºC during 4 hours. After adding 6M urea, the reaction mixture 
was evaporated to 8ml and was loaded onto a gel filtration column (P-6) eluted by 1 M 
HOAc. The desired peptide, DILP8 with Cys(Acm) at A-24 and B-16, was then dissolved 
in 75% HOAc by addition of Iodine in MeOH and 4M HCl in dioxane. 
Synthesis of A Chain: DILP8A SS13-18 , C14-MeOBzl , C24-Acm (Mw 3093): 
Fmoc-Cys(Acm)-O-TrtCl polymer (Nova) 700 mg (~ 1mmol/g) was used as solid sup-
port. Cleavage condition: 25ml TFA, 1.5ml m-Cresol, 1.5ml TIPS, 0.5ml Trifluoroacet-
ic acid 1 hr, precipitated with ether. Solid material was filtered off, and dissolved in 
~50% MeCN (~400ml), oxidized with Iodine. Crude peptide was purified by HPLC 
25x250mm, 0-100% CH3CN in 0.1%TFA linear gradient, desired fraction combined 
and lyophilized.
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Activation of A Chain : DILP8A SS13-18 , C14-SSPyr , C24-Acm (Mw 3081): 
When DILP8A SS13-18 , C14-MeOBzl , C24-Acm peptide in 25ml TFA, aldrithiol-2 
(~150mg) and 1ml thioanisole were added. The reaction mixture was kept 45min at 
room temperature and then diluted with ether. The solids was collected by filtration. 
The crude peptide was purified by HPLC 25x250mm, 0-100% CH3CN in 0.1%TFA lin-
ear gradient, desired fraction combined and lyophilized.
Synthesis of B Chain : DILP8B C16-Acm (Mw 3478):
Fmoc-Asp(tBu)-O-TrtCl polymer (Nova) 700 mg (~ 1mmol/g) was used as solid 
support. Cleavage conditions: 25ml TFA, 1.5ml m-Cresol, 1.5ml TIPS, 0.5ml Trifluo-
roacetic acid 1 hr. The reaction mixture was precipitated with ether. The crude pep-
tide was purified by HPLC 25x250mm, 0-100% CH3CN in 0.1%TFA linear gradient, 
desired fraction combined and lyophilized.
Coupling of A and B Chain : DILP8AB SSA13-A18 , SSA14-B3 , CysA24-Acm , 
CysB16-Acm :
Activated A-chain (DILP8A SS13-18 , C14-SSPyr , C24-Acm) and B-chain (DILP8B 
C16-Acm) were dissolved in 50% AcOH (25ml) and kept at 50 °C. The completion 
of reaction was controlled by HPLC during 4 hours. After addition of 6ml 6M urea, 
the reaction volume has been reduced to 7-8ml by evaporation. The peptide was 
isolated by gel-filtration (P-6, 1M AcOH), and desired fractions were combined and 
lyophilized
Formation of DILP8 : SSA13-A18 , SSA14-B3 , SSA24-B16:
DILP8AB SSA13-A18 , SSA14-B3 , CA24-Acm , CB16-Acm (~25mg) was dissolved 
in 20 ml 75% AcOH (25ml) and followed by addition of 1ml 4M HCl and Iodine 
(MeOH) in dioxane into mixture. The reaction was monitored by HPLC. Excess of 
iodine was reduced with ascorbic acid. In the next step, the reaction mixture was 
diluted with water to ~100ml. The peptide was purified by HPLC 25x250mm, 0-100% 
CH3CN in 0.1%TFA 150min linear gradient, and desired fractions were combined 
and lyophilized.
The reaction mixture was monitored by HPLC and the excess iodine was reduced 
with ascorbic acid. Purification of the peptide was achieved by HPLC (Figure 2). Pure 
synthetic DILP8 showed a single peak on analytical LC/MS with corrected molecular 
ion. This synthesized DILP8 provides us the opportunity to explore the novel biologi-
cal activity of DILP8.
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